id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
ajlm-1029	Ansumana, Rashid; Bah, Fatmata; Biao, Kan; Harding, Doris; Jalloh, Mohamed B.; Kelly, Ann H.; Koker, Francess; Koroma, Zikan; Momoh, Mambu; Rogers, Mohamed H.; Rogers, James; Street, Alice; Vernooij, Eva; Wurie, Isatta	Building diagnostic systems in Sierra Leone: The role of point-of-care devices in laboratory strengthening	2020		.htm	text/html	4650	218	42	To expedite their deployment, a series of cross-sectional research and development initiatives were launched including innovative financing mechanisms, data-sharing platforms, public-private partnerships and accelerated regulatory pathways.1 A number of novel EVD diagnostics were trialled in Sierra Leone.2,3,4,5,6,7 Guided by a national testing algorithm, rapid diagnostic tests (RDTs) such as ReEBOV (Corgenix, Broomfield, Colorado, United States) and the OraQuick (Orasure Technologies, Bethlehem, Pennsylvania, United States), intended for use at the primary care level, and automated real-time reverse transcription polymerase chain reaction (RT-PCR), primarily run on the benchtop, underwent rapid validation and performance evaluation through the World Health Organization’s Emergency Use and Assessment Listing mechanism.8,9,10,11 The ReEBOV test was temporarily deployed in a field setting in Sierra Leone and another rapid test, the DSTL EVD Rapid Diagnostic Antigen Test, developed by the Defence Science Technology Laboratory in the United Kingdom, was validated in hospital and primary care settings.6 The meeting featured short presentations as well as a panel discussion with Sierra Leonean laboratory scientists and health workers, who shared their first-hand experience using rapid diagnostic tests during the Ebola outbreak.	cache/ajlm-1029.htm	txt/ajlm-1029.txt